Close Menu

David Hamilton at Venture Beat covers the latest events at CIRM, the California Institute for Regenerative Medicine. While the $3 billion stem cell program has started disbursing funds to scientists, bad news continues to hound the endeavor. Most recently, Arlene Chiu, the interim chief scientific officer, resigned unexpectedly, Hamilton writes. Her departure follows on the heels of the resignation earlier this year of Zach Hall, CIRM's first president.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.